首页 | 本学科首页   官方微博 | 高级检索  
检索        

心肺复苏后血浆可溶性选择素与脓毒症关系的研究
引用本文:康登伟,吕兰萍,王香玲,曹昭,柏希山,郑堃,蔡学涛,段炳菊,刘兴先,李自力,李培杰.心肺复苏后血浆可溶性选择素与脓毒症关系的研究[J].中国急救复苏与灾害医学杂志,2008,3(1):11-14.
作者姓名:康登伟  吕兰萍  王香玲  曹昭  柏希山  郑堃  蔡学涛  段炳菊  刘兴先  李自力  李培杰
作者单位:1. 兰州市安宁区人民医院内科,甘肃,730070
2. 甘肃盐锅峡水电厂职工医院内科
3. 甘肃省紧急医疗救援中心急症科
摘    要:目的探讨心肺复苏(CPR)后是否会出现血浆可溶性P-选择素、E-选择素增高,并评价其临床意义。方法CPR后存活≥48h的43例患者次日晨采集肘静脉血,采用ELISA定量测定血浆sE-选择素、sP-选择素,按是否发生全身炎症反应综合征(SIRS)及脓毒症进行分组,并与40例非危重病患者作对照。结果①CPR后29例(29/43)发生SIRS,SIRS组血浆sP-选择素水平显著高于非SIRS组及对照组(均P〈0.01),SIRS组与非SIRS组血浆sE-选择素水平虽差异无统计学意义(P〉0.05),但却均高于对照组(均P〈0.01)。②CPR后1周内19例患者发展为脓毒症,脓毒症组血浆sP-选择素水平显著高于非脓毒症组(P〈0.05),二组血浆sE-选择素水平差异无统计学意义(P〉0.05);③CPR后死亡患者血浆sE-选择素水平明显高于存活患者(P〈0.01),但两组血浆sP-选择素水平差异无统计学意(P〉0.05)。结论SIRS是CPR后一种常见的非特异性反应,血浆sP-选择素水平可能帮助识别脓毒症高危患者,血浆sE-选择素水平可能有助于CPR后不良预后的判断。

关 键 词:心肺复苏  可溶性选择素  脓毒症
文章编号:1673-6966(2008)01-0011-04
修稿时间:2007年11月10

Relationship of Plasma soluble sP-and sE-selectin levels to systemic inflammatory response syndrome and sepsis after successful cardiopulmonary resuscitation
Institution:KANG Deng-wei, LV Lan-ping, WANG Xiang-ling, et al (Department of Internal Medicine, People's Hospital of Anning District, Lanzhou 730070)
Abstract:Objective To investigate the plasma levels of soluble P (sP)-selectin and soluble E-(sE-) selectin after successful cardiopulmonary resuscitation (CPR) and its relationship to the incidence of systemic inflammatory response syndrome (SIRS) and sepsis. Methods Peripheral blood samples were collected from 43 patients surviving ≥48 hours after CPR, 29 of which suffered from SIRS and 19 of which suffered from sepsis within 1 week after CPR (14 belonging to the SIRS group and 5 belonging to the non-SIRS group), on the second day after successful CPR. The plasma levels of sE- and sP-selectin were determined by ELISA. Forty non-critically ill patients were used as control group. Results Twenty of the 29 SIRS group patients and 8 of the 14 non-SIRS group patients died 1 -23 days after the collection of blood samples. The plasma level of sP- selectin of the SIRS group was (261.8±97.6) ng/ml, significantly higher than those of the non-SIRS and control groups (110.2±48.8 )ng/ml and (113.2±84 )ng/ml respectively, both P 〈0.01]. The Plasma level of sE-selectin of the SIRS group was (102.7±48.1) ng/ml, significantly higher than those of the non-SIRS and control groups (98.6±47.5 )ng/ml and (43.3±17.20)ng/ml respectively, both P 〈0.01]. The Plasma levels of sP- and sE-selectin of the non-SIRS group were both significantly higher than those of the control group too (both P 〈0.01). The Plasma level of sP-and sE-selectin of the SIRS group were (346.9±206.5) and (109.5±52.4)ng/ml respectively, both significantly higher than those of the non-sePsis group (158.0±156.4 )and (98.1±50.7) ng/ml respectively, both P 〈0.01]. The Plasma levels of sP- of the non-survivor group was(356.1±198.0) ng/ml, not significantly higher than that of the survivor group (216.4±167.1) ng/ml, and the sE-selectin of the non-survivor group was (149.4±57.9)ng/ ml, significantly higher then that of the survivor group (98.0±53) ng/ml, P 〈0.01]. Conclusio
Keywords:Cardiopulmonary resuscitation  Soluble seleetin  Sepsis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号